Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention (Q37293352)

19 August 2017

1 reference

title

Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention (English)

1 reference

19 August 2017

0 references

1 reference

Jennifer M Peterson

1

1 reference

PubMed ID

18853344

19 August 2017

Denis C Guttridge

series ordinal

2

1 reference

19 August 2017

1 January 2008

1 reference

International Reviews of Immunology

19 August 2017

1 reference

19 August 2017

27

1 reference

19 August 2017

5

1 reference

19 August 2017

375-387

1 reference

Integrating cell-signalling pathways with NF-kappaB and IKK function

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Shared principles in NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Function and genetics of dystrophin and dystrophin-related proteins in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Do immune cells promote the pathology of dystrophin-deficient myopathies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Macrophages in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

NF-kappaB-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

The ER-overload response: activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Endoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Inflammatory myopathies: clinical, diagnostic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Immunomodulation by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Curcumin as "Curecumin": from kitchen to clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Systemic administration of L-arginine benefits mdx skeletal muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Repeated exposure to pyrrolidine-dithiocarbamate induces peripheral nerve alterations in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Pyrrolidine dithiocarbamate induces bovine cerebral endothelial cell death by increasing the intracellular zinc level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802302389

10.1080/08830180802302389

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18853344